Loading data for DRUG — first visit, this takes a few seconds.
Bright Minds Biosciences Inc. (DRUG)
NasdaqCM: DRUG
· 即時價格 · USD
63.18
-1.82 (-2.80%)
收盤價： Sep 11, 2026, 3:59 PM
63.18
+0.00%
盤後: 7:30 PM
股價、關鍵數字和最新消息，都在這一頁。
Bright Minds Biosciences Inc.（DRUG）股價、分析與資料
-2.80% (1D)
| 買價 | 66.27 |
| 市值 | 620M |
| 營收 (ttm) | n/a |
| 淨利（ttm） | -24.5M |
| -0.11 | |
| -2 | |
| n/a | |
| -10.68 | |
| P/B (ttm) | 2.80 |
| P/S (ttm) | 0.00 |
| 財報日期 | Dec 22, 2026 |
| 賣價 | 68.06 |
| 成交量 | 129,198 |
| 20 日平均成交量 | 213,078 |
| 開盤價 | 66.25 |
| 前收盤價 | 65.00 |
| 當日區間 | 62.69 - 66.25 |
| 52 週範圍 | 44.25 - 123.75 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 DRUG
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathi...
完整的公司簡介財報驚奇
Bright Minds Biosciences 已於 Aug 14, 2026 公布季度財報：
- 營收為 $0 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 -0.24 超出預期 1.40, 年增 67.57% 成長.
第 1 頁，共 2 頁